What is the share price of PREVEST DENPRO LTD (PREVEST) today?
The share price of PREVEST as on 9th September 2026 is ₹387.85. The stock prices are volatile and keep changing through the day depending upon various factors and market conditions.What is the return on PREVEST DENPRO LTD (PREVEST) share?
The past returns of PREVEST DENPRO LTD (PREVEST) share are- Past 1 week: 1.00%
- Past 1 month: 0.48%
- Past 3 months: 5.39%
- Past 6 months: -6.43%
- Past 1 year: -35.80%
- Past 3 years: -19.12%
- Past 5 years: 104.62%
What are the peers or stocks similar to PREVEST DENPRO LTD (PREVEST)?
The peers or stocks similar to PREVEST DENPRO LTD (PREVEST) include:What is the market cap of PREVEST DENPRO LTD (PREVEST) share?
Market capitalization, short for market cap, is the market value of a publicly traded company's outstanding shares. The market cap of PREVEST DENPRO LTD (PREVEST) is ₹486.66 Cr as of 9th September 2026.What is the 52 week high and low of PREVEST DENPRO LTD (PREVEST) share?
The 52-week high of PREVEST DENPRO LTD (PREVEST) is ₹605 and the 52-week low is ₹318.15.What is the PE and PB ratio of PREVEST DENPRO LTD (PREVEST) stock?
The P/E (price-to-earnings) ratio of PREVEST DENPRO LTD (PREVEST) is 23.76. The P/B (price-to-book) ratio is 3.90.Which sector does PREVEST DENPRO LTD (PREVEST) belong to?
PREVEST DENPRO LTD (PREVEST) belongs to the Health Care sector & Health Care Equipment & Supplies sub-sector.How to buy PREVEST DENPRO LTD (PREVEST) shares?
You can directly buy PREVEST DENPRO LTD (PREVEST) shares on Tickertape. Simply sign up, connect your demat account and place your order.
PREVEST DENPRO LTD
PREVEST Share Price
BSE₹387.850.00% (+0.00)
High
—
—
Low
—
—
Returns
—
—
1D
1W
1M
1Y
5Y
Max
SIP
1D
1W
1M
1Y
5Y
Max
SIP
PREVEST Stock Scorecard
Performance
LowHasn't fared well - amongst the low performers
Valuation
HighSeems to be overvalued vs the market average
Growth
LowLagging behind the market in financials growth
Profitability
HighShowing good signs of profitability & efficiency
Entry point
AvgThe stock is overpriced but is not in the overbought zone
Red flags
LowNo red flag found
How to use scorecard? Learn more
PREVEST Performance & Key Metrics
PREVEST Performance & Key Metrics
| No LabelNo Label | PB RatioPB Ratio | Dividend YieldDiv. Yield |
|---|---|---|
| 22.41 | 3.90 | — |
| Sector PESector PE | Sector PBSector PB | Sector Div YldSctr Div Yld |
|---|---|---|
| 46.35 | 5.85 | 0.49% |
PREVEST Analyst Ratings & Forecast
—
Analyst Ratings data is currently unavailable for this stockPrice Upside
Earnings Growth
Rev. Growth
PREVEST Company Profile
Prevest Denpro Ltd is an India-based manufacturer of dental materials, offering a comprehensive range of products including adhesives, cements, restorative materials, and impression materials. Their portfolio serves various dental specialties such as endodontics, prosthodontics, and orthodontics, with products distributed in over 80 countries.
PE Ratio
41.53
41.53
1Y Return
13.22%
13.22%
Buy Reco %
77.78
77.78
POLYMED
PE Ratio
54.10
54.10
1Y Return
14.19%
14.19%
Buy Reco %
80.00
80.00
PE Ratio
75.98
75.98
1Y Return
21.72%
21.72%
TARSONS
PE Ratio
128.17
128.17
1Y Return
1.28%
1.28%
Buy Reco %
100.00
100.00
ONEGLOBAL
PE Ratio
16.73
16.73
1Y Return
106.73%
106.73%
Buy Reco %
0.00
0.00
PREVEST Sentiment Analysis
PREVEST Sentiment Analysis
New
Crisp summary & key insights to decode earnings calls instantly
PREVEST Stock Summary · July 2026
Strong FY26 growth with resilient profitability and targeted investments in digital dentistry was the central message, as revenue from operations rose 13.9% year‑on‑year to INR 71.81 crore while EBITDA margin remained robust at 38.6%. Management struck a constructive, disciplined tone, crediting cost controls, manufacturing efficiencies and higher capacity utilization for mitigating inflationary pressure and delivering material quarterly margin improvement, even as they acknowledged a slight moderation versus the prior year. Export momentum (up 17.58%) and a broad presence across roughly 90–92 countries were highlighted as diversification strengths alongside renewed domestic push into Tier‑2/3 markets and new Oradox and disinfectant product commercialization. Strategic priorities centered on scaling digital dentistry and 3D capabilities — with rapid Omni printer traction and a multi‑product R&D pipeline including import‑substitution work — while newly commissioned digital and resin lines operate at early utilization and legacy capacity sits around 67–68%. Near term, management expects the Dubai online entity to begin sales next month and sees gradual ramping of new lines and digital initiatives driving revenue in the coming years.
PREVEST Stock Growth Drivers
PREVEST Stock Growth Drivers
6Robust financial performance and resilient profitability
The company delivered steady, disciplined growth in FY2025‑26 with revenue from operations rising 13.9% year‑on‑year
Strong international expansion and U.S. market traction
Export revenues outpaced domestic growth, rising about 17.5% (exports recorded at 17.58%), reflecting improved demand
PREVEST Stock Challenges
PREVEST Stock Challenges
3Geopolitical and trade disruptions are slowing growth and destabilizing international operations
The company reported that tariff developments, geopolitical tensions and ongoing conflict materially disrupted international trade,
Regulatory rollout and export logistics failures depressed Oradox sales and disrupted shipments
Oradox revenue declined about 2% year‑on‑year, a drop management attributed to export disruptions tied to
PREVEST Forecast
PREVEST Forecasts
Forecast data is currently unavailable
Forecast data is currently unavailable
Price
Price Upside
Revenue
Revenue Growth
Earnings
Earnings Per Share
PREVEST
PREVEST
Income
Balance Sheet
Cash Flow
Quarterly Normal View
PREVEST Income Statement
PREVEST Income Statement
Quarterly Normal View
| Quarter | mar 2024 | jun 2024 | sep 2024 | dec 2024 | mar 2025 | jun 2025 | sep 2025 | dec 2025 | mar 2026 | jun 2026 | ||||||||||
|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|
| Total Revenue | 17.07 | 14.22 | 17.31 | 16.04 | 19.53 | 16.93 | 19.83 | 19.61 | 20.35 | 20.38 | ||||||||||
Operating & Other expenses | 10.24 | 8.84 | 10.46 | 9.74 | 11.91 | 10.45 | 11.96 | 12.66 | 12.03 | 12.30 | ||||||||||
EBITDA | 6.83 | 5.38 | 6.85 | 6.30 | 7.62 | 6.48 | 7.87 | 6.95 | 8.32 | 8.08 | ||||||||||
| Depreciation/Amortization | 0.46 | 0.48 | 0.47 | 0.48 | 0.47 | 0.49 | 0.50 | 0.51 | 0.51 | 0.52 | ||||||||||
| PBIT | 6.37 | 4.90 | 6.38 | 5.82 | 7.15 | 5.99 | 7.37 | 6.44 | 7.81 | 7.56 | ||||||||||
| Interest & Other Items | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 | ||||||||||
| PBT | 6.37 | 4.90 | 6.38 | 5.82 | 7.15 | 5.99 | 7.37 | 6.44 | 7.81 | 7.56 | ||||||||||
| Taxes & Other Items | 1.60 | 1.23 | 1.57 | 1.29 | 2.01 | 1.58 | 1.83 | 1.72 | 1.99 | 1.92 | ||||||||||
| Net Income | 4.77 | 3.67 | 4.81 | 4.53 | 5.14 | 4.41 | 5.54 | 4.72 | 5.82 | 5.64 | ||||||||||
| EPS | 3.98 | 3.06 | 4.01 | 3.77 | 4.28 | 3.67 | 4.62 | 3.93 | 4.85 | 4.70 |
PREVEST Company Updates
PREVEST Stock Peers
PREVEST Past Performance & Peer Comparison
PREVEST Past Performance & Peer Comparison
Comparing 3 stocks from
Health CareHealth Care Equipment & Supplies
Compare valuation on Screener
Health CareHealth Care Equipment & Supplies
Valuation
Technical
Forecast
Compare valuation on Screener| Stock | PE RatioPE Ratio | PB RatioPB Ratio | Div. YieldDividend Yield |
|---|---|---|---|
| PREVEST DENPRO LTD | 23.76 | 3.90 | — |
| Inventurus Knowledge Solutions Ltd | 41.53 | 10.70 | — |
| Poly Medicure Limited | 54.10 | 5.53 | 0.20% |
| Molbio Diagnostics Limited | 75.98 | 9.67 | — |
PREVEST Stock Price Comparison
Compare PREVEST with any stock or ETFCompare PREVEST with any stock or ETF
PREVEST
PREVEST Holdings
PREVEST Shareholdings
PREVEST Promoter Holdings Trend
PREVEST Promoter Holdings Trend
PREVEST Institutional Holdings Trend
PREVEST Institutional Holdings Trend
Total Retail Holding
Increasing retail holding can be considered bad as it can reflect that institutions and promoters are selling their stake which is being absorbed by retail investors.
In last 3 months, retail holding in the company has almost stayed constant
Foreign Institutional Holding
Foreign Institutional Holding is quantum of stock held by foreign large-quantities-trading entities. Increasing value indicates growing support and comfort for the stock
In last 3 months, foreign institutional holding of the company has almost stayed constant
PREVEST Shareholding Pattern
PREVEST Shareholding Pattern
PREVEST Shareholding History
PREVEST Shareholding History
Foreign Institutions
Hmm, looks like there hasn't been any net deal activity in the last 6 monthssmallcases containing PREVEST stock
smallcases containing PREVEST stock
Looks like this stock is not in any smallcase yet.
PREVEST Events
PREVEST Events
PREVEST Dividend Trend
No dividend trend available
Dividends
Corp. Actions
Announcements
Legal Orders
Dividends
PREVEST Dividend Trend
No dividend trend available
PREVEST Upcoming Dividends
PREVEST Upcoming Dividends
No upcoming dividends are available
PREVEST Past Dividends
PREVEST Past Dividends
Cash Dividend
Ex DateEx DateSep 4, 2026
Final
Final | Div/Share: ₹1.00
Dividend/Share
₹1.00
Ex DateEx Date
Sep 4, 2026
Cash Dividend
Ex DateEx DateSep 3, 2025
Final
Final | Div/Share: ₹1.00
Dividend/Share
₹1.00
Ex DateEx Date
Sep 3, 2025
Cash Dividend
Ex DateEx DateAug 30, 2024
Final
Final | Div/Share: ₹1.00
Dividend/Share
₹1.00
Ex DateEx Date
Aug 30, 2024
Cash Dividend
Ex DateEx DateAug 23, 2023
Final
Final | Div/Share: ₹1.00
Dividend/Share
₹1.00
Ex DateEx Date
Aug 23, 2023
PREVEST Stock News & Opinions
PREVEST Stock News & Opinions
Articles & Videos
Earnings
Earnings
Prevest Denpro Ltd consolidated sales up 0.69% on year in Q2FY2026Prevest Denpro Ltd share price softened by 0.62% to Rs 378.45 after the company's net profit eased 3.09% to Rs 5.64 crore, while revenue from operations improved marginally 0.69% to Rs 19.07 crore in Q2FY26 over Q1FY26. The market capitalization of Medical Equipment & Supplies industry group stocks on BSE stood at Rs 22727.54 crore, easing 0.95%. It has inched up 5.07% over last one week and heading higher by 14.92% in last one month while the market capitalization of Prevest Denpro Ltd has eased by 1.13% and 9.60% in the same period respectively. Profit before tax (PBT) of Prevest Denpro Ltd stood at Rs 7.56 crore in Q2 FY26, rallying 26.21% year-on-year, and declining 3.20% quarter-on-quarter. EBITDA came in at Rs 5 crore, surging by 31.40% YoY and slipping 1.09% sequentially. Total expenses saw a slight increase of 2.23% to Rs 12.82 crore in Q2FY26 over Q2FY25. During the quarter, cost of materials consumed stood at Rs 4.8 crore, soaring by 27.66% YoY, while employee benefits expense was at Rs 3.77 crore, expanding by 9.91% YoY. For the TTM ended FY26, revenue from operations improved 11.70% to Rs 63.03 crore, while net profit improved by 12.52% to Rs 18.16 crore, compared to previous TTM. EBITDA witnessed a strong improvement of 1661% to Rs 18.01 crore, and PBT rose 13.16% to Rs 24.25 crore compared to previous TTM. The company's consolidated net cash flow from operating activities stood at Rs 14.82 crore in FY26, as against Rs 11.62 crore in FY25. Prevest Denpro Ltd plunged by 32.18% in last one year, underperforming the benchmark BSE Sensex which has softened by 2.56% during the same period.
4 weeks agoCapital Market - Live
Corporate
Corporate
Prevest Denpro Limited sets record date for potential final dividend paymentPrevest Denpro Limited has set Saturday, September 05, 2026, as the record date for the purpose of paying a final dividend on equity shares for the financial year 2025-26, contingent upon declaration at the company's 27th Annual General Meeting, according to a regulatory filing with the BSE Limited.
4 weeks agoCapital Market - Live
Corporate
Corporate
Prevest Denpro Limited to review financial results and potential dividend at August meetingPrevest Denpro Limited will hold a board meeting on Tuesday, August 11, 2026, to consider and approve the Unaudited Standalone and Consolidated Financial Results for the quarter ended June 30, 2026, and to recommend the Final Dividend for the Financial Year 2025–26.
1 month agoCapital Market - Live
Earnings
Earnings
Prevest Denpro consolidated net profit rises 13.23% in the March 2026 quarterNet profit of Prevest Denpro rose 13.23% to Rs 5.82 crore in the quarter ended March 2026 as against Rs 5.14 crore during the previous quarter ended March 2025. Sales rose 2.66% to Rs 18.94 crore in the quarter ended March 2026 as against Rs 18.45 crore during the previous quarter ended March 2025. For the full year,net profit rose 12.83% to Rs 20.49 crore in the year ended March 2026 as against Rs 18.16 crore during the previous year ended March 2025. Sales rose 13.93% to Rs 71.81 crore in the year ended March 2026 as against Rs 63.03 crore during the previous year ended March 2025. ParticularsQuarter EndedYear EndedMar. 2026Mar. 2025% Var.Mar. 2026Mar. 2025% Var. Sales18.9418.45 3 71.8163.03 14 OPM %36.4835.45 -34.4035.03 - PBDT8.327.62 9 29.6226.15 13 PBT7.817.15 9 27.6124.25 14 NP5.825.14 13 20.4918.16 13 Powered by Capital Market - Live
3 months agoCapital Market - Live
Corporate
Corporate
Prevest Denpro to table resultsPrevest Denpro will hold a meeting of the Board of Directors of the Company on 27 May 2026.
3 months agoCapital Market - Live
Earnings
Earnings
Prevest Denpro consolidated net profit rises 4.19% in the December 2025 quarterNet profit of Prevest Denpro rose 4.19% to Rs 4.72 crore in the quarter ended December 2025 as against Rs 4.53 crore during the previous quarter ended December 2024. Sales rose 23.48% to Rs 18.46 crore in the quarter ended December 2025 as against Rs 14.95 crore during the previous quarter ended December 2024. ParticularsQuarter EndedDec. 2025Dec. 2024% Var. Sales18.4614.95 23 OPM %31.4234.85 - PBDT6.956.30 10 PBT6.445.82 11 NP4.724.53 4 Powered by Capital Market - Live
6 months agoCapital Market - Live
Earnings
Earnings
Prevest Denpro standalone net profit rises 15.47% in the December 2025 quarterNet profit of Prevest Denpro rose 15.47% to Rs 5.15 crore in the quarter ended December 2025 as against Rs 4.46 crore during the previous quarter ended December 2024. Sales rose 23.04% to Rs 18.37 crore in the quarter ended December 2025 as against Rs 14.93 crore during the previous quarter ended December 2024. ParticularsQuarter EndedDec. 2025Dec. 2024% Var. Sales18.3714.93 23 OPM %33.8634.36 - PBDT7.386.23 18 PBT6.875.75 19 NP5.154.46 15 Powered by Capital Market - Live
6 months agoCapital Market - Live
Corporate
Corporate
Prevest Denpro schedules board meetingPrevest Denpro will hold a meeting of the Board of Directors of the Company on 14 February 2026.Powered by Capital Market - Live
6 months agoCapital Market - Live
Earnings
Earnings
Prevest Denpro consolidated net profit rises 14.94% in the September 2025 quarterNet profit of Prevest Denpro rose 14.94% to Rs 5.54 crore in the quarter ended September 2025 as against Rs 4.82 crore during the previous quarter ended September 2024. Sales rose 14.57% to Rs 18.64 crore in the quarter ended September 2025 as against Rs 16.27 crore during the previous quarter ended September 2024. ParticularsQuarter EndedSep. 2025Sep. 2024% Var. Sales18.6416.27 15 OPM %35.8435.71 - PBDT7.876.85 15 PBT7.376.38 16 NP5.544.82 15 Powered by Capital Market - Live
9 months agoCapital Market - Live
Earnings
Earnings
Prevest Denpro standalone net profit rises 15.08% in the September 2025 quarterNet profit of Prevest Denpro rose 15.08% to Rs 5.57 crore in the quarter ended September 2025 as against Rs 4.84 crore during the previous quarter ended September 2024. Sales rose 14.76% to Rs 18.66 crore in the quarter ended September 2025 as against Rs 16.26 crore during the previous quarter ended September 2024. ParticularsQuarter EndedSep. 2025Sep. 2024% Var. Sales18.6616.26 15 OPM %35.9135.73 - PBDT7.906.88 15 PBT7.406.41 15 NP5.574.84 15 Powered by Capital Market - Live
9 months agoCapital Market - Live
In last 6 months, promoter holding in the company has almost stayed constant
Pledged promoter holdings is insignificant